PERCEPTIVE ADVISORS LLC
Top Portfolio Positions
90 positions ·
$5,084,742,423 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
2,035,986 | $655,974,329 | 12.90% | |
| CELC |
Celcuity Inc.
Healthcare
|
3,127,200 | $356,938,608 | 7.02% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
1,531,421 | $350,281,925 | 6.89% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
8,285,461 | $229,507,269 | 4.51% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
5,258,903 | $208,883,627 | 4.11% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
2,373,795 | $206,448,951 | 4.06% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
3,783,225 | $190,825,869 | 3.75% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
1,580,505 | $161,922,737 | 3.18% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
4,423,974 | $139,355,181 | 2.74% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
1,230,879 | $129,734,646 | 2.55% |
Portfolio Trend
Holdings in CELC
Shares Held
Position Value (USD)
10 of 10 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $356,938,608 | 3,127,200 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $315,198,348 | 3,160,200 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $146,042,158 | 2,956,319 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $21,803,326 | 1,633,208 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $23,882,640 | 2,362,279 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $30,922,232 | 2,362,279 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $35,221,579 | 2,362,279 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $38,694,130 | 2,362,279 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $51,025,226 | 2,362,279 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $21,582,541 | 1,481,300 | Shares | Sole | 2024-02-26 | |
| No quarters match your search. | ||||||